Followers | 1103 |
Posts | 27838 |
Boards Moderated | 10 |
Alias Born | 01/11/2016 |
Tuesday, August 17, 2021 10:06:07 AM
Recent VRPX News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2024 10:20:24 PM
- Virpax Pharmaceuticals, Inc. Announces Closing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants • Business Wire • 11/15/2024 09:09:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 10:00:42 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 11/13/2024 10:01:01 PM
- Virpax Pharmaceuticals, Inc. Announces Pricing of $5.0 Million Public Offering of Common Stock and Pre-Funded Warrants • Business Wire • 11/13/2024 02:15:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/13/2024 05:15:06 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/07/2024 10:01:31 PM
- Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer • GlobeNewswire Inc. • 11/05/2024 01:30:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/28/2024 08:08:45 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/18/2024 09:28:22 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/10/2024 09:08:24 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 10/10/2024 09:07:21 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/09/2024 09:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:30:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:45:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:30:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 08:12:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:11:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/13/2024 01:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 11:35:20 AM
- Virpax Pharmaceuticals Reports 2024 Second Quarter Results and Recent Developments • Business Wire • 08/13/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 08:26:43 PM
- Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference August 14-15 • Business Wire • 08/08/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:26:23 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 08:30:56 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM